Literature DB >> 7126178

Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.

N Ototani, M Kikuchi, Z Yosizawa.   

Abstract

Finback-whale (Balaenoptera physalus L.) heparin was partially digested with a purified heparinase and an octasaccharide with high affinity for antithrombin III was isolated from the digest by gel filtration, followed by affinity chromatography on a column of antithrombin III immobilized on Sepharose 4B. This octasaccharide possessed high inhibitory activity for Factor Xa in the presence of antithrombin III, but was essentially inactive for thrombin-antithrombin III reaction. The anticoagulant activity determined by the activated-partial-thromboplastin-time method was very low (40-70 units/mg), although the initial whale heparin exhibited high activity (252 units/mg). On the basis of the results of chemical analyses, 13C n.m.r. spectrum and enzymic studies with purified heparinase, heparitinases 1 and 2, the predominant structure of the octasaccharide was proposed as follows: delta UA(2S) alpha 1 leads to 4GlcNS alpha 1 leads to 4IdUA alpha 1 leads to 4GlcNAc(6S) alpha 1 leads to 4GlcUA beta 1 leads to 4GlcNS(3S) alpha 1 leads to 4IdUA(2S) alpha 1 leads to 4GlcNS. Comparing this structure with those of the heparin octasaccharides so far reported, the presence of the critical structural elements for binding to antithrombin III was suggested in the pentasaccharide region situated at the reducing end of this octasaccharide. Binding to antithrombin III of the critical structural elements alone would appear to elicit the acceleration of the Factor Xa-antithrombin III reaction. Additional structural elements required for the acceleration of the thrombin-antithrombin III reaction and for the manifestation of high anticoagulant activity are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126178      PMCID: PMC1158441          DOI: 10.1042/bj2050023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Enzymic degradation products of omega-heparin (whale heparin).

Authors:  N Ototani; K Nakamura; Z Yosizawa
Journal:  J Biochem       Date:  1974-06       Impact factor: 3.387

2.  The disaccharide repeating-units of heparan sulfate.

Authors:  P Hovingh; A Linker
Journal:  Carbohydr Res       Date:  1974-10       Impact factor: 2.104

3.  Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion.

Authors:  S Suzuki; H Saito; T Yamagata; K Anno; N Seno; Y Kawai; T Furuhashi
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

Review 4.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

5.  Correlation between structure and function of heparin.

Authors:  R D Rosenberg; L Lam
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Stability of ester sulfates in heparin to solvolysis and dilute acid treatment.

Authors:  M Kosakai; Z Yosizawa
Journal:  J Biochem       Date:  1979-07       Impact factor: 3.387

7.  Guanosine-5'-diphosphate-3'-diphosphate (ppGpp) and the regulation of protein breakdown in Escherichia coli.

Authors:  R Voellmy; A L Goldberg
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

8.  Sulfated oligosaccharides isolated from the deamination products of heparins.

Authors:  M Kosakai; Z Yosizawa
Journal:  J Biochem       Date:  1981-06       Impact factor: 3.387

9.  Multiple functional domains of the heparin molecule.

Authors:  G M Oosta; W T Gardner; D L Beeler; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Structures of two sulfated unsaturated disaccharides isolated from enzymatic digests of omega-heparin (whale heparin).

Authors:  N Ototani; Z Yosizawa
Journal:  J Biochem       Date:  1974-09       Impact factor: 3.387

View more
  1 in total

1.  Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.

Authors:  Joana C Santos; Juliana M F Mesquita; Celso L R Belmiro; Carolina B M da Silveira; Christian Viskov; Pierre A Mourier; Mauro S G Pavão
Journal:  Thromb Res       Date:  2007-05-04       Impact factor: 3.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.